Besides providing new insights into CFTR biology and suggesting possible therapeutic targets in CF, the network biology approach delineated in this work provides a framework applicable to other human diseases related to the traffic and function of PM transport proteins. The gene discussed is PROS1; the disease is cystic fibrosis.